MED.F MEDICLIN Aktiengesellschaft
- Market cap
- EUR 249M
- P/E
- 7.6x
- P/B
- 0.91x
- ROE
- 14.6%
- Dividend yield
- 0.76%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MED.F undervalued?
Graham numberMED.F trades 44.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MEDICLIN Aktiengesellschaft fundamental analysis
No fundamental analysis for MEDICLIN Aktiengesellschaft yet.
MEDICLIN Aktiengesellschaft stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; urology; and others. The company also provides services in the areas of ENT and ac…
Full company profileMEDICLIN Aktiengesellschaft financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MEDICLIN Aktiengesellschaft annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 580M | 609M | 645M | 673M | 660M | 673M | 705M | 730M | 749M | 785M | 781M |
| Gross Profit | 472M | 496M | 526M | 552M | 547M | 551M | 572M | 595M | 623M | 662M | 657M |
| Operating Income | 23.2M | 5.73M | 14.1M | 21.4M | -695K | 10.9M | 18.5M | 11.7M | 50.4M | 52.5M | 70.3M |
| EBITDA | - | 27.2M | 37.6M | 93.7M | 77.7M | 85.4M | 91.8M | 101M | 106M | 118M | 126M |
| Net Income | 16.5M | 3.91M | 7.72M | 9.66M | -9.00M | 1.46M | 9.44M | -10.8M | 24.8M | 25.5M | 40.9M |
| EPS | - | 0.08 | 0.16 | 0.20 | -0.19 | 0.03 | 0.20 | -0.23 | 0.52 | 0.54 | 0.86 |
| Balance Sheet | |||||||||||
| Total Assets | 347M | 369M | 445M | 898M | 887M | 881M | 916M | 881M | 906M | 841M | 867M |
| Total Liabilities | 165M | 183M | 253M | 707M | 711M | 698M | 707M | 684M | 683M | 592M | 586M |
| Shareholders' Equity | 182M | 186M | 192M | 191M | 177M | 183M | 209M | 196M | 223M | 249M | 280M |
| Cash & Short-term Investments | 41.6M | 26.9M | 33.8M | 37.2M | 100M | 120M | 88.0M | 115M | 108M | 72.2M | 91.7M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 29.9M | 20.0M | 28.0M | 69.6M | 119M | 82.0M | 34.6M | 78.0M | 80.6M | 102M | 94.3M |
| Capital Expenditure | 26.2M | 31.3M | 42.8M | 41.3M | 22.3M | 15.2M | 24.4M | 37.6M | 44.7M | 51.4M | 43.6M |
| Free Cash Flow | - | -16.4M | -16.7M | 24.7M | 92.9M | 65.0M | 8.62M | 40.4M | 35.9M | 51.0M | 50.7M |
| Ratios | |||||||||||
| ROE | 9.1% | 2.1% | 4.0% | 5.1% | -5.1% | 0.8% | 4.5% | -5.5% | 11.2% | 10.2% | 14.6% |
| ROA | 4.8% | 1.1% | 1.7% | 1.1% | -1.0% | 0.2% | 1.0% | -1.2% | 2.7% | 3.0% | 4.7% |
| Net Profit Margin | 2.9% | 0.6% | 1.2% | 1.4% | -1.4% | 0.2% | 1.3% | -1.5% | 3.3% | 3.2% | 5.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MEDICLIN Aktiengesellschaft dividends
- Dividend yield
- 0.76%
- Forward dividend
- 0.04 EUR
- Payout ratio
- 7.5%
- Ex-dividend date
- May 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 1.90M | 0.04 | 7.5% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | EUR 2.38M | 0.05 | 24.6% |
| 2018 | EUR 2.38M | 0.05 | 30.8% |
| 2017 | EUR 2.38M | 0.05 | 60.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns MEDICLIN Aktiengesellschaft
- Insiders 87.73%
- Institutions 0.57%
- Public & others 11.70%
- Shares outstanding 47.5M
- Free float 11.4M
MEDICLIN Aktiengesellschaft company profile
- Company name
- MEDICLIN Aktiengesellschaft
- Ticker
- MED.F
- ISIN
- DE0006595101
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 7,055
- Fiscal year end
- December
- Address
- Okenstr. 27, Offenburg, Germany, 77652
- Phone
- 49 781 488 0
- Website
- mediclin.de
About MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; urology; and others. The company also provides services in the areas of ENT and acute outpatient services. It owns 31 clinical facilities, rehabilitation care, 6 nursing care facilities, and 9 medical care centers in 11 German federal states. The company was incorporated in 1994 and is headquartered in Offenburg, Germany.
MEDICLIN Aktiengesellschaft management
10- Mr. Tino FritzCFO & Member of the Management Board · born 1976
- Mr. Thomas PiefkeCOO & Member of Management Board
- Mr. Mario WaideleHead of Group Accounting
- Ender GulcanHead of Investor Relations & ESG
- Ms. Katja KiesewetterHead of Law
- Mr. Jörg StörmerHead of Purchasing & Medical Technology
- Ms. Carin EmminghausHead of Payroll & Application Management
- Dr. Ralf BürgyHead of Quality Medicine & Head of Internal Auditing
- Mr. Frank HeubergerHead of Finance & Accounting
- Ms. Bärbel MerzHead of Group Controlling